======= CYP4V2 =======
== Gene Information ==
* **Official Symbol**: CYP4V2
* **Official Name**: cytochrome P450 family 4 subfamily V member 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=285440|285440]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q6ZWL3|Q6ZWL3]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CYP4V2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CYP4V2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/608614|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a member of the cytochrome P450 hemethiolate protein superfamily which are involved in oxidizing various substrates in the metabolic pathway. It is implicated in the metabolism of fatty acid precursors into n-3 polyunsaturated fatty acids. Mutations in this gene result in Bietti crystalline corneoretinal dystrophy. [provided by RefSeq, Jul 2008].
* **UniProt Summary**: Omega-hydroxylase that oxidizes medium-chain saturated fatty acids and polyunsaturated omega-3 fatty acids, and which plays a role in fatty acid and steroid metabolism in the eye (PubMed:19661213, PubMed:22772592). Catalyzes the omega- hydroxylation of medium-chain saturated fatty acids such as laurate, myristate and palmitate in an NADPH-dependent pathway. The substrate specificity is higher for myristate > laurate > palmitate (C14>C16>C12) (PubMed:19661213). Acts as a polyunsaturated omega-3 fatty acids hydroxylase by mediating oxidation of docosahexaenoate (DHA) to 22-hydroxydocosahexaenoate (PubMed:22772592). Also produces some 21-hydroxydocosahexaenoate. Also converts eicosapentaenoate (EPA) to 20- hydroxyeicosapentaenoate (20-OH-EPA) (PubMed:22772592). {ECO:0000269|PubMed:19661213, ECO:0000269|PubMed:22772592}.
|p450|
|fatty acid omega-oxidation|
|oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen|
|monooxygenase activity|
|fatty acid oxidation|
|lipid oxidation|
|retinoid metabolic process|
|diterpenoid metabolic process|
|terpenoid metabolic process|
|iron ion binding|
|sterol metabolic process|
|isoprenoid metabolic process|
|heme binding|
|lipid modification|
|visual perception|
|sensory perception of light stimulus|
|steroid metabolic process|
|fatty acid metabolic process|
|organic hydroxy compound metabolic process|
|monocarboxylic acid metabolic process|
|carboxylic acid metabolic process|
|endoplasmic reticulum membrane|
|cellular lipid metabolic process|
|oxidation-reduction process|
|sensory perception|
|oxoacid metabolic process|
|organic acid metabolic process|
|lipid metabolic process|
|nervous system process|
|small molecule metabolic process|
|system process|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8121
* **Expression level (log2 read counts)**: 3.96
{{:chemogenomics:nalm6 dist.png?nolink |}}